Placebo
MND2112H33
Phase 3 small_molecule completed
Quick answer
Placebo for Hypertriglyceridemia is a Phase 3 program (small_molecule) at Mochida Pharmaceutical Company, with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Mochida Pharmaceutical Company,
- Indication
- Hypertriglyceridemia
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed